Rejuvenate Bio secures $4M to advance gene therapy for a devastating heart disease
BioProcess International - 27-Aug-2024A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Join the club for FREE to access the whole archive and other member benefits.
Company delivering age-reversing gene therapies for animals
At Rejuvenate Bio, we aspire to treat aging and age-related diseases afflicting animals, such as MVD. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University. Our targeted gene therapies treat pets and are directed at curing specific disease states associated with old age. These therapies have the potential to extend overall health and lifespan.
Visit website: https://www.rejuvenatebio.com/
Details last updated 21-Nov-2019
25-Feb-2023
The club's Longevity Cafe Meetup group will be discussing the latest research by Rejuvenate Bio (FREE)
A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Therapy used OSKM genes to potentially extend lifespan and reverse ageing signs
Single dose injection targets root causes, offering long-term relief & improved quality of life
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Shown to work at a cellular level in humans, too, so a therapeutic could be developed soon
Discusses animal trials, potential human trials, reeducating the FDA and improvements in technology
Good summary of some major investments in life extension companies
Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...